VictoryShares US 500 Enhanced Volatility Wtd ETF

67.53

+1.261.89%

Post-market: 67.45-0.0800-0.12%16:08 EDT

Volume:7.93K

Turnover:532.15K

Market Cap:411.93M

PE:337.65

High:67.55

Open:66.72

Low:66.72

Close:66.28

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer

Business Wire

·

13 Mar

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CFO"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CFO"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CFO\",,,,,undefined,":{"symbol":"CFO","market":"US","secType":"STK","nameCN":"VictoryShares US 500 Enhanced Volatility Wtd ETF","latestPrice":67.53,"timestamp":1741982400000,"preClose":66.275,"halted":0,"volume":7930,"hourTrading":{"tag":"盘后","latestPrice":67.45,"preClose":67.53,"latestTime":"16:08 EDT","volume":1,"amount":65.52,"timestamp":1741982893097},"delay":0,"changeRate":0.018936,"change":1.255,"floatShares":6100000,"shares":6100000,"eps":0.2,"lyrEps":0,"amount":532145.8695,"amplitude":0.012524,"volumeRatio":0.8792158996942072,"dividePrice":0.88568,"prevYearClose":68.94,"fiveDayClose":69.21,"twentyDayClose":71.5689,"impliedVol":0.1339,"impliedVolPercentile":0.656},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CFO\",,,,,undefined,":{"symbol":"CFO","floatShares":6100000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8792158996942072,"shares":6100000,"dividePrice":0.88568,"high":67.55,"amplitude":0.012524,"preClose":66.275,"low":66.72,"week52Low":62.13,"pbRate":"--","week52High":74.0723,"institutionHeld":0,"latestPrice":67.53,"eps":0.2,"divideRate":0.013115,"volume":7930,"delay":0,"ttmEps":0.2,"open":66.72,"prevYearClose":68.94,"prevWeekClose":69.21,"prevMonthClose":70.93,"prevQuarterClose":68.94,"fiveDayClose":69.21,"twentyDayClose":71.5689,"sixtyDayClose":71.4078},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CFO\",params:#limit:5,,,undefined,":[{"date":"2025-03-10","symbol":"CFO","amount":0.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-10","defaultRemindTime":1741613400000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-11","payableDate":"2025-03-10","currency":"USD","dateTimestamp":1741579200000,"payDate":"2025-03-11"},{"date":"2025-02-07","symbol":"CFO","amount":0.045497,"announcedDate":"2025-02-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-07","defaultRemindTime":1738938600000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-10","payableDate":"2025-02-07","currency":"USD","dateTimestamp":1738904400000,"payDate":"2025-02-10"},{"date":"2025-01-08","symbol":"CFO","amount":0.110614,"announcedDate":"2025-01-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-08","defaultRemindTime":1736346600000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-09","payableDate":"2025-01-08","currency":"USD","dateTimestamp":1736312400000,"payDate":"2025-01-09"},{"date":"2024-12-12","symbol":"CFO","amount":0.093477,"announcedDate":"2024-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-12","defaultRemindTime":1734013800000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-13","payableDate":"2024-12-12","currency":"USD","dateTimestamp":1733979600000,"payDate":"2024-12-13"},{"date":"2024-11-07","symbol":"CFO","amount":0.040606,"announcedDate":"2024-11-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-07","defaultRemindTime":1730989800000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-08","payableDate":"2024-11-07","currency":"USD","dateTimestamp":1730955600000,"payDate":"2024-11-08"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CFO\",market:\"US\",,,undefined,":[{"executeDate":"2015-03-17","recordDate":"2015-03-19","paymentDate":"2015-03-20","value":0.0992701,"currency":"USD"},{"executeDate":"2015-06-16","recordDate":"2015-06-18","paymentDate":"2015-06-19","value":0.0962452,"currency":"USD"},{"executeDate":"2015-09-22","recordDate":"2015-09-24","paymentDate":"2015-09-25","value":0.1092497,"currency":"USD"},{"executeDate":"2015-12-28","recordDate":"2015-12-30","paymentDate":"2015-12-31","value":0.1653246,"currency":"USD"},{"executeDate":"2016-03-08","recordDate":"2016-03-10","paymentDate":"2016-03-11","value":0.1177036,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CFO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CFO\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CFO\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519844043","title":"Press Release: OCI Global Reports H2 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2519844043","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519844043?lang=en_us&edition=fundamental","pubTime":"2025-03-14 15:07","pubTimestamp":1741936020,"startTime":"0","endTime":"0","summary":"AMSTERDAM, March 14, 2025 /PRNewswire/ -- Hassan Badrawi, CEO of OCI Global commented:. \"2024 has been a year of pivotal transformation for OCI Global. We have successfully executed a series of strategic transactions, significantly strengthened our balance sheet, and delivered exceptional returns to our shareholders. These milestones reflect our agility in navigating evolving market conditions while reinforcing our deep value creation ethos.Specifically, in the second half of 2024, we announced the divestment of OCI Methanol to Methanex and completed the divestments of our entire Fertiglobe equity stake to ADNOC, Iowa Fertilizer Company to Koch Industries, and OCI Clean Ammonia([1]) to Woodside Energy. These transactions will collectively amount to over $11.6 billion in gross proceeds, which has allowed us to repay approximately $1.8 billion in debt and return $3.3 billion in cash distributions to shareholders in Q4 2024. An additional cash distribution of up to $1 billion  is further ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO","CEO"],"gpt_icon":0},{"id":"2519893359","title":"Xencor Appoints Todd Simpson to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2519893359","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519893359?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:01","pubTimestamp":1741896060,"startTime":"0","endTime":"0","summary":"PASADENA, Calif., March 13, 2025----Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced the appointment of Todd Simpson to its board of directors. Mr. Simpson has more than 40 years of experience in chief financial officer  roles at multiple biopharmaceutical companies and in public accounting. Most recently he served as CFO at Seagen Inc. through its acquisition in 2023.\"Mr. Simpson is an accomplished finance and operations executive with broad experience in corporate strategy, and he played a key role in transforming a small development-stage biotech company into one of the most successful growth companies in the biopharmaceutical industry. We are thrilled to welcome Todd to our Board, and we look forward to working with him,\" said Bassil Dahiyat, Ph.D., president and chief executive officer at Xencor.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/xencor-appoints-todd-simpson-board-200100413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CFO","BK4139","XNCR"],"gpt_icon":0},{"id":"2519865121","title":"Why This High-Yield Warren Buffett Stock Is Falling This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2519865121","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519865121?lang=en_us&edition=fundamental","pubTime":"2025-03-14 03:23","pubTimestamp":1741893780,"startTime":"0","endTime":"0","summary":"Shares of Sirius XM struggled after management warned about potential softness in revenue.The stock has struggled in recent years as management tries to execute a turnaround.However, Sirius has received a big vote of confidence from the Oracle of Omaha and his team of investors.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/13/why-this-high-yield-warren-buffett-stock-is-fallin/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1914381329.SGD","BRK.B","BK4550","LU0648001328.SGD","LU1363072403.SGD","LU1074936037.SGD","US10Y.BOND","IE00B3S45H60.SGD","LU0130102774.USD","LU0971096721.USD","IE0034235303.USD","CFO","BK4534","US6M.BOND","LU0053666078.USD","BK4588","IE00BWXC8680.SGD","IE00BKDWB100.SGD","IE00B775SV38.USD","LU0256863811.USD","LU0149725797.USD","LU0742534661.SGD","IE00B1XK9C88.USD","US7Y.BOND","IE00BK4W5L77.USD","BRK.A","BK4176","LU0234570918.USD","BK4585","LU0787776722.HKD","LU0170899867.USD","BK4581","LU0251142724.SGD","LU0154236417.USD","IE000M9KFDE8.USD","US30Y.BOND","IE00B1BXHZ80.USD","LU0683600562.USD","LU0980610538.SGD","LU0251131958.USD","US12M.BOND","US3Y.BOND","LU0048573561.USD","LU0417517546.SGD","LU1571399168.USD","BK4533","LU1366333091.USD","US5Y.BOND","US2Y.BOND","LU0640476718.USD"],"gpt_icon":1},{"id":"2519639839","title":"Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2519639839","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519639839?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:30","pubTimestamp":1741869000,"startTime":"0","endTime":"0","summary":"Ms. Romano brings decades of experience with a strong track record in financial strategy and corporate development. WALTHAM, Mass., March 13, 2025----Vicarious Surgical Inc.  , a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the appointment of Sarah Romano as Chief Financial Officer , effective April 1, 2025.Ms. Romano will oversee Vicarious Surgical’s financial strategy, leveraging decades of financial leadership experience in capital markets. With exceptional strategic acumen, Ms. Romano has a proven record of driving growth and value creation in public companies, particularly in the healthcare sector, through successful fundraising and M&A initiatives.Founded in 2014, Vicarious Surgical is a next generation robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vicarious-surgical-announces-appointment-sarah-123000252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","RBOT","CFO"],"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200}]}}